Charl van Zyl is the Chief Executive Officer (CEO) of H. Lundbeck A/S.

He joined Lundbeck in 2023 and brings more than 23 years of experience from commercial international management roles within the pharmaceutical industry, most recently in the field of immunology and neurology from UCB where he served as Executive Vice President (EVP) and Head of Neurology globally, responsible for corporate activities in Europe and international markets. 

Charl has a degree in Medical Biochemistry from the University of Cape Town, South Africa.

His career includes positions such as EVP at BSN Medical, Corporate VP & Commercial Leader EMEA at Bausch & Lomb, CEO at JADO Technologies, Head of Marketing and Sales at Novartis Pharma and Business Unit Manager at Eli Lilly and Company. He has lived and worked in South Africa, United States, Japan, Switzerland, Belgium and now Denmark. 

On October 9 at Maersk Tower, Charl will take part in the panel debate Public-Private Partnerships: A Catalyst for European Competitiveness and Health?